Kornitzer Capital Management Inc. KS increased its stake in athenahealth, Inc. (NASDAQ:ATHN) by 19.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 205,250 shares of the health services provider’s stock after buying an additional 33,390 shares during the period. Kornitzer Capital Management Inc. KS owned about 0.52% of athenahealth worth $28,848,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently made changes to their positions in ATHN. Norges Bank bought a new position in shares of athenahealth during the fourth quarter valued at approximately $20,750,000. State Street Corp increased its position in shares of athenahealth by 3.7% in the first quarter. State Street Corp now owns 502,823 shares of the health services provider’s stock valued at $56,662,000 after buying an additional 17,718 shares during the last quarter. Rockefeller Financial Services Inc. increased its position in shares of athenahealth by 13.1% in the first quarter. Rockefeller Financial Services Inc. now owns 8,445 shares of the health services provider’s stock valued at $952,000 after buying an additional 975 shares during the last quarter. BlackRock Inc. increased its position in shares of athenahealth by 30,642.6% in the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock valued at $180,286,000 after buying an additional 1,594,643 shares during the last quarter. Finally, UBS Asset Management Americas Inc. increased its position in shares of athenahealth by 14.0% in the first quarter. UBS Asset Management Americas Inc. now owns 22,931 shares of the health services provider’s stock valued at $2,584,000 after buying an additional 2,820 shares during the last quarter.
athenahealth, Inc. (ATHN) opened at 140.37 on Friday. The stock has a 50 day moving average price of $142.63 and a 200 day moving average price of $125.50. athenahealth, Inc. has a 12-month low of $90.11 and a 12-month high of $158.66. The company has a market capitalization of $5.60 billion, a price-to-earnings ratio of 178.13 and a beta of 1.77.
athenahealth (NASDAQ:ATHN) last issued its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.12. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. The firm had revenue of $301.10 million during the quarter, compared to the consensus estimate of $298.68 million. During the same quarter in the previous year, the firm posted $0.34 EPS. The company’s revenue for the quarter was up 15.0% compared to the same quarter last year. On average, analysts expect that athenahealth, Inc. will post $1.92 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This piece was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.com-unik.info/2017/08/12/kornitzer-capital-management-inc-ks-raises-stake-in-athenahealth-inc-athn-updated.html.
Several research analysts have commented on ATHN shares. William Blair reaffirmed a “market perform” rating on shares of athenahealth in a report on Friday, July 21st. Cantor Fitzgerald reissued an “overweight” rating and issued a $140.00 price objective (up from $118.00) on shares of athenahealth in a research note on Friday, May 19th. Argus initiated coverage on athenahealth in a research note on Friday, July 7th. They issued a “hold” rating on the stock. Citigroup Inc. reissued a “buy” rating and issued a $163.00 price objective (up from $128.00) on shares of athenahealth in a research note on Monday, June 5th. Finally, J P Morgan Chase & Co set a $136.00 price objective on athenahealth and gave the company a “hold” rating in a research note on Wednesday, July 19th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and thirteen have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $148.64.
In related news, SVP Jonathan D. Porter sold 422 shares of athenahealth stock in a transaction on Friday, July 21st. The shares were sold at an average price of $154.00, for a total transaction of $64,988.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Jonathan Bush sold 4,000 shares of athenahealth stock in a transaction on Thursday, May 18th. The shares were sold at an average price of $125.85, for a total transaction of $503,400.00. Following the transaction, the chief executive officer now owns 319,807 shares in the company, valued at approximately $40,247,710.95. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 22,905 shares of company stock worth $3,120,107. 3.20% of the stock is owned by corporate insiders.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
What are top analysts saying about athenahealth Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for athenahealth Inc. and related companies.